IP Library Granted Patent US 8,110,398
Granted Patent B2
US 8,110,398 · App. 12/843,706 · Granted Feb 7, 2012

Stable cell lines and methods for evaluating gastrointestinal absorption of chemicals

Assignee: Absorption Systems Group, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,110,398
App. No.
12/843,706
Granted
Feb 7, 2012
Kind
B2
Abstract

Nucleic acids and vectors for interfering with the expression of membrane efflux transport proteins in cells that express such proteins are provided. Also provided are cells and cell lines comprising such nucleic acids and vectors. Methods for screening chemicals and biomolecules for gastrointestinal absorption in animals, and kits for practicing such methods are also provided.

Claims (12)

1. A host cell transformed with a vector comprising a nucleic acid sequence encoding a nucleic acid molecule for inhibiting expression of Multidrug Resistance-Associated Protein 2 (MRP2), wherein the nucleic acid sequence comprises SEQ ID NO: 17, 18, 19, 20, or 21.

2. The host cell of claim 1 , wherein the cell expresses Multidrug Resistance-Associated Protein 2 (MRP2).

3. The host cell of claim 1 , wherein the cell is an intestinal epithelial cell.

4. A cell culture comprising the host cell of claim 3 .

5. The host cell of claim 1 , wherein said host cell has been deposited with the American Type Culture Collection and assigned accession number PTA-8751.

6. The host cell of claim 1 , wherein the cell is a Caco-2 cell.

7. The host cell of claim 1 , wherein the cell is derived from a Caco-2 cell.

8. The host cell of claim 1 , wherein the cell is a C2BBe1 cell.

9. A kit for determining the absorption characteristics of a chemical compound, comprising the cell of claim 1 .

10. A nucleic acid sequence comprising SEQ ID NO: 17, 18, 19, 20, or 21.

11. A nucleic acid encoded by the nucleic acid sequence of claim 10 .

12. A vector comprising a nucleic acid sequence encoding a nucleic acid molecule for inhibiting expression of Multidrug Resistance-Associated Protein 2 (MRP2), wherein the nucleic acid sequence comprises SEQ ID NO: 17, 18, 19, 20, or 21.

Assignments (3)
CHANGE OF NAME Recorded Aug 16, 2023
From: ABSORPTION SYSTEMS LLC
To: PHARMARON (EXTON) LAB SERVICES LLC
Reel/Frame 064615/0410 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2020
From: ABSORPTION SYSTEMS GROUP, LLC
To: ABSORPTION SYSTEMS LLC
Reel/Frame 052210/0520 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2020
From: ABSORPTION SYSTEMS GROUP, LLC
To: ABSORPTION SYSTEMS LLC
Reel/Frame 052098/0174 →
Continuity (4)
Division 11938065 · Nov 9, 2007
Provisional Application 60892665 · Mar 2, 2007
Provisional Application 60857938 · Nov 10, 2006
Related Publication 20100311082A1 · Dec 9, 2010